Carsten Brunn
President, CEO & Chairman of the BoardDr. Carsten Brunn, Ph.D. serves as President, Chief Executive Officer & Chairman of the Board since October 29, 2025 and was Director of Cartesian Therapeutics, Inc. since December 2018 until October 29, 2025. He served as an Independent Director at Surface Oncology, Inc. since June 2022 until September 08, 2023. He serves as President, Chief Executive Officer and Director of Selecta Biosciences, Inc. since December 1, 2018. He served as the Chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan. Dr. Brunn served as President of Pharmaceuticals Business - Americas at Bayer Aktiengesellschaft and Bayer Corporation since January 17, 2017. Previously, Dr. Brunn served as the President of Bayer's Pharmaceuticals Commercial Operations in Japan, a role he held March 2013. He joined Bayer in 2011 as Global Head of Primary Care based in Beijing, China. Prior to joining Bayer, Dr. Brunn held a number of senior leadership roles at companies including Eli Lilly, Novartis and Bausch & Lomb in Europe, Asia and the United States. He serves on the Board of Directors of the Biotechnology Innovation Organization (BIO). Dr. Brunn graduated from the University of Freiburg in Germany with a Master of Science in Pharmaceutical Science. In addition, he studied at the University of Washington under a research scholarship and later received his PhD in Chemistry from the University of Hamburg in Germany. He completed his executive education at the London Business School.
公司职务
- 公司名称Cartesian Therapeutics, Inc.股票代码RNAC职务President, CEO & Chairman of the Board共事同僚
- BTBlaine T. DavisChief Financial Officer
- EEEmily EnglishChief Operating Officer
- JSJune SeymourChief Accounting Officer
- CGChar GrossFractional Chief People Officer
- TCTimothy C. BarabeIndependent Director
- PJPatrick J. ZennerLead Independent Director
- KMKemal MalikIndependent Director
- MSMichael Scott SingerIndependent Director
